165 related articles for article (PubMed ID: 21175583)
1. Biochemical characterization of a novel high-affinity and specific plasma kallikrein inhibitor.
Kolte D; Bryant J; Holsworth D; Wang J; Akbari P; Gibson G; Shariat-Madar Z
Br J Pharmacol; 2011 Apr; 162(7):1639-49. PubMed ID: 21175583
[TBL] [Abstract][Full Text] [Related]
2. PF-04886847 (an inhibitor of plasma kallikrein) attenuates inflammatory mediators and activation of blood coagulation in rat model of lipopolysaccharide (LPS)-induced sepsis.
Kolte D; Bryant JW; Gibson GW; Wang J; Shariat-Madar Z
Cardiovasc Hematol Agents Med Chem; 2012 Jun; 10(2):154-66. PubMed ID: 22352684
[TBL] [Abstract][Full Text] [Related]
3. High molecular weight kininogen activates B2 receptor signaling pathway in human vascular endothelial cells.
Kolte D; Osman N; Yang J; Shariat-Madar Z
J Biol Chem; 2011 Jul; 286(28):24561-71. PubMed ID: 21586566
[TBL] [Abstract][Full Text] [Related]
4. Glycosaminoglycans affect the action of human plasma kallikrein on kininogen hydrolysis and inflammation.
Gozzo AJ; Nunes VA; Carmona AK; Nader HB; von Dietrich CP; Silveira VL; Shimamoto K; Ura N; Sampaio MU; Sampaio CA; Araújo MS
Int Immunopharmacol; 2002 Dec; 2(13-14):1861-5. PubMed ID: 12489800
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
6. Bradykinin release from high molecular weight kininogen and increase in plasma kallikrein-like activity following sensory stimulation by food in the rat.
Rothschild AM; Gomes EL; Fortunato IC
Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):483-8. PubMed ID: 9826071
[TBL] [Abstract][Full Text] [Related]
7. Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein.
Nishikawa K; Shibayama Y; Kuna P; Calcaterra E; Kaplan AP; Reddigari SR
Blood; 1992 Oct; 80(8):1980-8. PubMed ID: 1391955
[TBL] [Abstract][Full Text] [Related]
8. Identification of lipopolysaccharide binding site on high molecular weight kininogen.
Perkins R; Ngo MD; Mahdi F; Shariat-Madar Z
Biochem Biophys Res Commun; 2008 Feb; 366(4):938-43. PubMed ID: 18083112
[TBL] [Abstract][Full Text] [Related]
9. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiogenesis by cleaved high molecular weight kininogen (HKa) and HKa domain 5.
McCrae KR; Doñate F; Merkulov S; Sun D; Qi X; Shaw DE
Curr Cancer Drug Targets; 2005 Nov; 5(7):519-28. PubMed ID: 16305348
[TBL] [Abstract][Full Text] [Related]
11. Endothelial-cell apoptosis induced by cleaved high-molecular-weight kininogen (HKa) is matrix dependent and requires the generation of reactive oxygen species.
Sun D; McCrae KR
Blood; 2006 Jun; 107(12):4714-20. PubMed ID: 16418331
[TBL] [Abstract][Full Text] [Related]
12. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
Meini S; Zanichelli A; Sbrojavacca R; Iuri F; Roberts AT; Suffritti C; Tascini C
Front Immunol; 2020; 11():2014. PubMed ID: 32849666
[TBL] [Abstract][Full Text] [Related]
13. The carboxyl terminus of bradykinin and amino terminus of the light chain of kininogens comprise an endothelial cell binding domain.
Hasan AA; Cines DB; Zhang J; Schmaier AH
J Biol Chem; 1994 Dec; 269(50):31822-30. PubMed ID: 7989355
[TBL] [Abstract][Full Text] [Related]
14. Two faces of high-molecular-weight kininogen (HK) in angiogenesis: bradykinin turns it on and cleaved HK (HKa) turns it off.
Guo YL; Colman RW
J Thromb Haemost; 2005 Apr; 3(4):670-6. PubMed ID: 15733059
[TBL] [Abstract][Full Text] [Related]
15. Structures of full-length plasma kallikrein bound to highly specific inhibitors describe a new mode of targeted inhibition.
Partridge JR; Choy RM; Silva-Garcia A; Yu C; Li Z; Sham H; Metcalf B
J Struct Biol; 2019 May; 206(2):170-182. PubMed ID: 30876891
[TBL] [Abstract][Full Text] [Related]
16. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
[TBL] [Abstract][Full Text] [Related]
17. Identification of Human Kinin-Forming Enzyme Inhibitors from Medicinal Herbs.
Madkhali H; Tarawneh A; Ali Z; Le HV; Cutler SJ; Khan IA; Shariat-Madar Z
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299400
[TBL] [Abstract][Full Text] [Related]
18. Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications for hereditary angioedema.
Joseph K; Tholanikunnel BG; Kaplan AP
J Allergy Clin Immunol; 2017 Jul; 140(1):170-176. PubMed ID: 27826093
[TBL] [Abstract][Full Text] [Related]
19. Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation.
Zhao Y; Qiu Q; Mahdi F; Shariat-Madar Z; Røjkjaer R; Schmaier AH
Am J Physiol Heart Circ Physiol; 2001 Apr; 280(4):H1821-9. PubMed ID: 11247797
[TBL] [Abstract][Full Text] [Related]
20. Cognac polyphenolic compounds increase bradykinin-induced nitric oxide production in endothelial cells.
Sall Diallo A; Sarr M; Mostefai HA; Carusio N; Pricci M; Andriantsitohaina R
Physiol Res; 2008; 57(6):885-892. PubMed ID: 18052679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
